Literature DB >> 28440427

Downregulation of miR-200c protects cardiomyocytes from hypoxia-induced apoptosis by targeting GATA-4.

Zhigang Chen1, Shaoli Zhang1, Changlei Guo1, Jianhua Li1, Wenfeng Sang2.   

Abstract

Hypoxia-induced cardiomyocyte apoptosis plays an important role in the development of ischemic heart disease. MicroRNAs (miRNAs or miRs) are emerging as critical regulators of hypoxia-induced cardiomyocyte apoptosis. miR-200c is an miRNA that has been reported to be related to apoptosis in various pathological processes; however, its role in hypoxia‑induced cardiomyocyte apoptosis remains unclear. In the present study, we aimed to investigate the potential role and underlying mechanism of miR-200c in regulating hypoxia‑induced cardiomyocyte apoptosis. We found that miR-200c was significantly upregulated by hypoxia in cardiomyocytes, as detected by reverse transcription-quantitative polymerase chain reaction (RT-qPCR). The lactate dehydrogenase, MTT, Annexin V/propidium iodide apoptosis and caspase-3 activity assays showed that downregulation of miR-200c markedly improved cell survival and suppressed the apoptosis of cardiomyocytes in response to hypoxia. Bioinformatics analysis and the dual-luciferase reporter assay demonstrated that miR-200c directly targeted the 3'-untranslated region of GATA-4, an important transcription factor for cardiomyocyte survival. RT-qPCR and western blot analysis showed that suppression of miR-200c significantly increased GATA-4 expression. Furthermore, downregulation of miR-200c upregulated the expression of the anti-apoptotic gene Bcl-2. However, the protective effects against hypoxia induced by the downregulation of miR‑200c were significantly abolished by GATA-4 knockdown. Taken together, our results suggest that downregulation of miR-200c protects cardiomyocytes from hypoxia-induced apoptosis by targeting GATA-4, providing a potential therapeutic molecular target for the treatment of ischemic heart disease.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28440427     DOI: 10.3892/ijmm.2017.2959

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  10 in total

1.  Amniotic fluid microRNA profiles in twin-twin transfusion syndrome with and without severe recipient cardiomyopathy.

Authors:  Emily C Willner; Henry L Galan; Bettina F Cuneo; Hilary A Hoffman; Bonnie Neltner; Eleanor L Schuchardt; Anis Karimpour-Fard; Shelley D Miyamoto; Carmen C Sucharov
Journal:  Am J Obstet Gynecol       Date:  2021-06-19       Impact factor: 10.693

2.  Intercellular transfer of miR-200c-3p impairs the angiogenic capacity of cardiac endothelial cells.

Authors:  Lara Ottaviani; Rio P Juni; Ricardo C de Abreu; Marida Sansonetti; Vasco Sampaio-Pinto; Julie Halkein; Jana C Hegenbarth; Nadja Ring; Kevin Knoops; Jordy M M Kocken; Carlos de Jesus; Auriane C Ernault; Hamid El Azzouzi; Frank Rühle; Servé Olieslagers; Hugo Fernandes; Lino Ferreira; Luca Braga; Monika Stoll; Diana S Nascimento; Leon J de Windt; Paula A da Costa Martins
Journal:  Mol Ther       Date:  2022-03-09       Impact factor: 12.910

Review 3.  MicroRNA as a Therapeutic Target in Cardiac Remodeling.

Authors:  Chao Chen; Murugavel Ponnusamy; Cuiyun Liu; Jinning Gao; Kun Wang; Peifeng Li
Journal:  Biomed Res Int       Date:  2017-09-28       Impact factor: 3.411

Review 4.  Therapeutic Approaches for Metastases from Colorectal Cancer and Pancreatic Ductal Carcinoma.

Authors:  Adriana G Quiroz-Reyes; Jose F Islas; Paulina Delgado-Gonzalez; Hector Franco-Villarreal; Elsa N Garza-Treviño
Journal:  Pharmaceutics       Date:  2021-01-14       Impact factor: 6.321

Review 5.  Post-Transcriptional Regulation of Molecular Determinants during Cardiogenesis.

Authors:  Estefania Lozano-Velasco; Carlos Garcia-Padilla; Maria Del Mar Muñoz-Gallardo; Francisco Jose Martinez-Amaro; Sheila Caño-Carrillo; Juan Manuel Castillo-Casas; Cristina Sanchez-Fernandez; Amelia E Aranega; Diego Franco
Journal:  Int J Mol Sci       Date:  2022-03-04       Impact factor: 5.923

6.  FAT10 Combined with Miltefosine Inhibits Mitochondrial Apoptosis and Energy Metabolism in Hypoxia-Induced H9C2 Cells by Regulating the PI3K/AKT Signaling Pathway.

Authors:  Yi Yao; Weikun Jia; Xiaofei Zeng; Yali Wang; Qiuxia Hu; Shiran Yu; Dongsheng He; Ying Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-18       Impact factor: 2.650

7.  miR-200c-3p Regulates Epitelial-to-Mesenchymal Transition in Epicardial Mesothelial Cells by Targeting Epicardial Follistatin-Related Protein 1.

Authors:  Elena Pontemezzo; Eleonora Foglio; Enza Vernucci; Alessandra Magenta; Marco D'Agostino; Sara Sileno; Elena Astanina; Federico Bussolino; Laura Pellegrini; Antonia Germani; Matteo Antonio Russo; Federica Limana
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

Review 8.  A MicroRNA Perspective on Cardiovascular Development and Diseases: An Update.

Authors:  Jose Francisco Islas; Jorge Eugenio Moreno-Cuevas
Journal:  Int J Mol Sci       Date:  2018-07-17       Impact factor: 5.923

9.  Down-regulation of miR-200c attenuates AngII-induced cardiac hypertrophy via targeting the MLCK-mediated pathway.

Authors:  Shan Hu; Mian Cheng; Xin Guo; Shun Wang; Beilei Liu; Hong Jiang; Congxin Huang; Gang Wu
Journal:  J Cell Mol Med       Date:  2019-01-25       Impact factor: 5.310

Review 10.  MicroRNAs in Cardiac Hypertrophy.

Authors:  Nadine Wehbe; Suzanne Awani Nasser; Gianfranco Pintus; Adnan Badran; Ali H Eid; Elias Baydoun
Journal:  Int J Mol Sci       Date:  2019-09-23       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.